Our Services
Medical Information
Helpful Resources
Published on: 6/14/2026
Lynch syndrome is an inherited condition caused by mismatch repair gene mutations that significantly increases lifetime risk for colorectal, endometrial, ovarian, gastric, and urinary tract cancers. Genetic testing is recommended for people with early-onset colorectal or endometrial cancer, multiple Lynch-related cancers, or a strong family history of these cancers.
When a pathogenic mutation is identified, an intensive screening plan typically includes:
Early detection through proactive screening dramatically improves outcomes, and risk-reducing surgeries may be considered for some carriers.
Because symptoms of Lynch-related cancers (such as rectal bleeding, abnormal uterine bleeding, persistent abdominal pain, or unexplained weight loss) can overlap with many common conditions, it's important to evaluate what you're experiencing before assuming the cause. Take a free, instant, online symptom check to better understand your symptoms and navigate the right next steps—whether that's genetic counseling, screening, or a conversation with your doctor.
Reviewed for medical accuracy: 06/14/2026
Lynch syndrome is an inherited condition that raises the risk of several cancers, most notably colorectal (colon) and endometrial (uterine) cancers. Understanding who should be tested and what screening steps to follow can help detect cancers early, when they're most treatable.
Lynch syndrome, also called hereditary nonpolyposis colorectal cancer (HNPCC), is caused by an inherited mutation in one of several DNA mismatch repair (MMR) genes. These genes normally fix errors during cell division. When they don't work correctly, cells can grow abnormally and form tumors.
Key facts:
Genetic testing for Lynch syndrome is not for everyone. Doctors recommend testing if you meet certain personal or family history criteria, suggesting an inherited cancer risk.
Consider testing if you have:
Discuss testing if you have:
Doctors often use established guidelines to decide on testing:
If you meet any of these criteria, talk to a genetics professional about testing.
If you and your doctor decide testing is appropriate:
Pre‐test counseling
A genetic counselor explains the benefits, risks, and possible outcomes.
Blood or saliva sample
Lab analysis looks for harmful mutations in MMR genes (MLH1, MSH2, MSH6, PMS2, EPCAM).
Post‐test counseling
Results interpretation and personalized risk management plan.
Once a Lynch syndrome diagnosis is confirmed, proactive screening is essential. Your doctor will tailor a plan based on which gene is affected and your personal and family history.
In addition to regular screening, you can lower your cancer risk with lifestyle changes:
Even with a clear screening plan, new symptoms warrant prompt attention. If you experience changes such as:
…you can start by using a Medically approved Symptom Checker Chat Bot to help you understand your symptoms and determine the appropriate level of care needed.
Genetic testing and lifelong screening can feel overwhelming. Remember:
Always speak to a doctor about anything that could be life threatening or serious. Your healthcare team can help interpret test results, recommend the best screening schedule, and support you through prevention strategies.
Lynch syndrome boosts lifetime risks for colorectal, endometrial, and other cancers, but early genetic testing and tailored screening can save lives. You should consider testing if you or close family members have early‐onset colorectal or related cancers. If a pathogenic mutation is found, follow intensified screening protocols:
For new or concerning symptoms, don't wait. Use a Medically approved LLM Symptom Checker to evaluate your symptoms and understand whether you need immediate medical attention, or contact your doctor right away. Always consult healthcare professionals for personalized guidance, and remember that proactive steps make a real difference in cancer prevention and early detection.
(References)
* Lipton L, Sachdev R, Beshay V, et al. Consensus guidelines for the management of patients with Lynch syndrome: An Australian perspective. *J Gastroenterol Hepatol*. 2020 Oct;35(10):1694-1701. doi: 10.1111/jgh.15106. Epub 2020 Jul 17. PMID: 32567705.
* Balma M, Soltys C, Vella J, et al. Lynch Syndrome: An Updated Review of Current Management. *Curr Oncol Rep*. 2023 Mar;25(3):311-322. doi: 10.1007/s11912-023-01344-9. Epub 2023 Feb 11. PMID: 36767936.
* Mork ME, Riegert-Johnson DL, Burt RW, et al. Lynch syndrome: The essentials. *J Natl Compr Canc Netw*. 2022 Jul;20(7):727-735. doi: 10.6004/jnccn.2022.7001. Epub 2022 Jun 29. PMID: 35767853.
* Bonadona V, Giraud G, Laurent M, et al. Current Concepts in Lynch Syndrome: Diagnosis, Management, and Therapeutic Implications. *Cancers (Basel)*. 2021 Jun 30;13(13):3313. doi: 10.3390/cancers13133313. PMID: 34209012.
* Stoffel EM, Kastrinos F. Lynch Syndrome: A Review of the Genetic Basis, Clinical Management, and Cancer Surveillance. *Cold Spring Harb Perspect Med*. 2020 Jan 2;10(1):a036281. doi: 10.1101/cshperspect.a036281. PMID: 31285375.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.